Literature DB >> 1617075

Enterococcal infections in surgical patients: the mystery continues.

R L Nichols1, A C Muzik.   

Abstract

The frequency of isolation of enterococci from surgical patients has increased significantly during the past decade, although the role of these organisms as pathogens in mixed infections remains a mystery. Bacteremia and other infections in which enterococci are the only pathogens frequently result in high morbidity and mortality among patients unless specific antimicrobial therapy is initiated promptly. Debate continues concerning the necessity for treatment with such agents when this organism is isolated as a component of a polymicrobial infecting flora. Our recent data indicate that enterococci are rarely isolated in postoperative infections after penetrating abdominal trauma if no gastrointestinal perforation has occurred. However, they were found in 56% of postoperative infections of patients with gastrointestinal perforation. In contrast, enterococci were isolated in only 9% of cultures of specimens from patients with secondary suppurative peritonitis. The occurrence of superinfection after therapy with a cephalosporin appears to be an important factor in this finding. Future studies are necessary to evaluate the efficacy of antibiotic treatment of enterococcal infections and to assess the need for prophylaxis against enterococci.

Entities:  

Mesh:

Year:  1992        PMID: 1617075     DOI: 10.1093/clinids/15.1.72

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  New developments and concepts in antimicrobial therapy for intra-abdominal infections.

Authors:  Z Younes; D A Johnson
Journal:  Curr Gastroenterol Rep       Date:  2000-08

2.  Identification of aerobically and anaerobically induced genes in Enterococcus faecalis by random arbitrarily primed PCR.

Authors:  B D Shepard; M S Gilmore
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

3.  Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis.

Authors:  Emilia Cercenado; Luis Torroba; Rafael Cantón; Luis Martínez-Martínez; Fernando Chaves; Jose Angel García-Rodríguez; Carmen Lopez-Garcia; Lorenzo Aguilar; César García-Rey; Nuria García-Escribano; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

4.  Adjunctive antimicrobial therapy for complicated appendicitis: bacterial overkill by combination therapy.

Authors:  J A Hopkins; S E Wilson; D G Bobey
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

5.  Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.

Authors:  J S Solomkin; S E Wilson; N V Christou; O D Rotstein; E P Dellinger; R S Bennion; R Pak; K Tack
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

6.  Acute bacterial cholangitis.

Authors:  Mamta K Jain; Rajeev Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

Review 7.  Are there patients with peritonitis who require empiric therapy for enterococcus?

Authors:  S Harbarth; I Uckay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-21       Impact factor: 3.267

8.  Can Enterococcal Infections Initiate Sepsis Syndrome?

Authors:  Peter Linden
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

9.  Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  J-H Lee; J-H Yoon; B H Kim; G E Chung; S J Myung; W Kim; Y J Kim; E-C Kim; H-S Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-09       Impact factor: 3.267

10.  Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.

Authors:  Joseph S Solomkin; Albert E Yellin; Ori D Rotstein; Nicolas V Christou; E Patchen Dellinger; Jose M Tellado; Osvaldo Malafaia; Alvaro Fernandez; Kyuran A Choe; Alexandra Carides; Vilas Satishchandran; Hedy Teppler
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.